The FDA has approved Jaypirca (pirtobrutinib) for adults with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma without a 17p deletion.
Vissa resultat har dolts eftersom de kan vara otillgängliga för dig.
Visa otillgängliga resultat